Motherhood
Where the smart capital is going: Maternal health innovation

By Theresa Neil, CEO of Femovate
For years we’ve known that maternal mortality remains too high, even in wealthier countries. The data is clear but meaningful change has been slow. Now, there are signs that things may finally be shifting.
New Momentum in Funding
Funding for maternal health is beginning to grow, and it’s coming from a broad mix of sources. Health systems, mission-driven funds, and hospital-backed venture arms are stepping in alongside traditional VCs.
Impact-Driven Investors at the Forefront
Much of the early momentum in maternal health innovation is coming from social impact funds and mission-aligned investors who have stepped in to support solutions where traditional capital has often fallen short.
These investors are not only backing new startups, they are helping reshape how maternal health challenges are identified, explored and solved.
Catalyst by Wellstar, a health system–backed innovation fund, just invested in Armor Medical, a company developing a wearable to monitor for early signs of postpartum haemorrhage.
The technology offers continuous insight during labor and postpartum, enabling faster intervention to help prevent the leading cause of maternal death.
“Catalyst is committed to backing transformative technologies that redefine standards of care,” said Jaimie Clark, Head of Innovation at Catalyst by Wellstar and Director of Innovation and Venture Strategy for Wellstar Health System.
“By investing in solutions that enable real-time detection and intervention, we’re not just funding innovation, we are helping save lives, protecting families, and building a safer future for mothers.”
Laerdal’s Million Lives Fund, based in Norway and the UK, has been investing globally in maternal and neonatal innovation since 2020.
They’ve supported early-stage companies like Novocuff and Ciconia Medical, and partnered with organisations such as MATTER, Walgreens, and University of Chicago Medicine to help startups address the biggest problems in maternal care.
Medicines360’s Innovation Hub continues to focus on advancing maternal health tools with both clinical rigor and patient centric design.
Their portfolio includes PeriPeach, a device designed to reduce severe perineal tearing, which won the 2025 Harvard President’s Innovation Challenge.
SwissHealth Ventures and Zürcher Kantonalbank, along with European Union Horizon 2020 funding, have backed Pregnolia, a Swiss startup developing a diagnostic tool to assess cervical stiffness and support preterm birth prevention.
These investors are filling a critical gap in funding and accelerating the pace of real, evidence-based innovation that supports better maternal outcomes.
Profit-Driven Investment is Gaining Ground
We’re also seeing a shift in who is funding maternal health.
While many early investments came from mission-driven or philanthropic sources, more profit-driven investors are now entering the space.
These ROI-focused backers expect strong returns and see maternal health as an underinvested opportunity. U.S. Venture Partners (USVP) led a $17 million Series A round for Delfina Care, an AI-enabled platform focused on pregnancy care.
TMV (March of Dimes Innovation Fund) and Foreground Capital co-led a $12 million Series A for Millie, a U.S. tech-enabled maternity clinic.
These are meaningful shifts.
They suggest that maternal health is no longer seen as a niche or philanthropic cause, but as a viable and scalable opportunity within the broader healthtech and digital care landscape.
Learning from the Fertility Investment Model
The fertility space shows what’s possible when capital and attention align. Over $10 billion has been invested in conception and IVF over the past decade.
That wave of funding brought new tools to market, expanded access, and improved outcomes. As investment in fertility has grown, attention is beginning to shift toward maternal health.
Turning Momentum Into Lasting Impact
To keep this momentum going, we’ll need continued support for clinical research, scalable product design, and thoughtful integration with care teams and health systems.
Early-stage capital remains essential, along with the infrastructure to help new tools reach the people who need them most.
Support from initiatives like Femovate, Springboard Enterprises, and Tech4Eva, along with investment groups such as Daya Ventures, is helping founders navigate early development, build credibility, and find the partnerships that move their solutions forward.
These networks are turning innovation into real-world impact.
Change is on the horizon.
With coordinated support from funders, founders, accelerators, and care providers, now is the time to reimagine maternal health and deliver better care for mothers and families around the world.
Pregnancy
Women’s health strategy a ‘missed opportunity,’ RCM says
Pregnancy
Scotland to publish dedicated miscarriage patient charter

Scotland is set to publish the UK’s first dedicated miscarriage patient charter, giving women and families clear information on NHS care and support.
Commissioned by the Scottish Government and developed with baby-loss charities Tommy’s, Held In Our Hearts and the Miscarriage Association, the charter sets out minimum standards for compassionate, clinically appropriate and culturally competent miscarriage care across Scotland.
It builds on the Scottish Government’s Delivery Framework for Miscarriage Care, which has already changed practice across NHS boards.
Jenni Minto, Scottish public health and women’s health minister, said: “Miscarriage is devastating, and for too long women have not had the care and support they deserve.
“That is changing. Scotland will become the first country in the UK to publish a miscarriage patient charter, meaning women know exactly how they will be supported by health services following their loss.”
Unlike previous UK-wide norms, where women were typically offered enhanced support only after three miscarriages, Scotland’s approach means women can receive appropriate support after their first miscarriage.
The charter also sets out clear rights and expectations so every woman, regardless of location or circumstance, understands the care she should receive.
It includes access to private rooms in hospitals rather than busy clinical areas or maternity settings, progesterone treatment where clinically appropriate, compassionate and culturally competent bereavement support, and clear information in 18 languages, including British Sign Language and audio formats.
Progesterone is a hormone that growing evidence suggests may help reduce the risk of miscarriage in certain cases when given to women who meet specific clinical criteria.
The Scottish Government said the charter is designed to ensure personalised, respectful care and to address long-standing inequalities experienced by women during miscarriage.
It is intended to provide clarity on the support women can expect, consistent standards across all NHS boards, stronger awareness and confidence among healthcare professionals, and better access to emotional and practical support services.
Charities involved in its development said many women still report feeling dismissed, uninformed or unsupported during miscarriage.
They said the new charter marks an important step towards making sure every woman feels heard, respected and cared for.
The charter aligns with Scotland’s wider Women’s Health Plan, which is improving care across reproductive, menstrual, maternal and perinatal health.
Recent national developments include greater investment in women’s health services, improved training for healthcare staff, new digital and in-person support tools, and targeted action to reduce inequalities in access and outcomes.
Together, these measures aim to create a more compassionate and equitable women’s health system.
Minto said: “This charter is a landmark moment.
“It tells women clearly what they should expect from their NHS, and it holds services to account for delivering it.
“Scotland is leading the way, and I am proud of the progress NHS boards and our charity partners have made together.”
The model is expected to inform wider UK discussions on miscarriage support, bereavement care and early pregnancy services.
The charter will be made publicly available, offering women, partners and families clear guidance on their rights and the standards they can expect when seeking care.
Motherhood
The maternity care crisis hiding in plain sight

By Adrianne Nickerson, founder and CEO, Oula
The numbers get the headlines. Maternal mortality rates. Access deserts. Workforce shortages. These are real and urgent problems, but they’re not the whole story.
There’s a quieter breakdown happening inside routine appointments, and it’s driving outcomes in ways that never show up in formal reports.
Women describe maternity care that feels rushed and transactional.
They talk about repeating their medical history at every visit, leaving appointments with questions they never got to ask, and receiving advice so generic it doesn’t seem to account for their actual lives.
These aren’t just complaints about bedside manner. They’re signals that the system is losing the thread, and when that happens, clinical risk follows.
A patient who doesn’t feel heard may decide a new symptom isn’t worth mentioning.
A patient who leaves an appointment without clear next steps may wait too long to call when something changes. These small moments of disconnection are where complications quietly take shape.
The system is structured to rush
This isn’t about individual clinicians failing women. It’s about a care model built around short, physician-led visits with limited coordination across roles — applied to pregnancies that are often medically and emotionally complex.
Clinicians are covering more ground in less time, and patients feel that compression. Women in marginalised communities feel it most acutely.
Reports of dismissal and bias are well-documented, and the consequences compound: when trust erodes, communication breaks down, and the window for early intervention narrows.
What women are actually asking for
Younger women in particular are entering maternity care with different expectations. They want explanations for recommendations, not just instructions.
They want to understand tradeoffs and have their preferences carry forward from one visit to the next. They’re not looking to reduce medical oversight, they’re looking for care that makes sense as a whole.
That’s driving real interest in collaborative care models that bring OBs, midwives, nurses, and behavioural health professionals into a coordinated framework.
When roles are clear and communication is shared rather than siloed, the experience changes, and so do outcomes.
Experience is clinical performance
Health systems are sophisticated at tracking infection rates and readmissions. The experience of care deserves the same level of attention, because it’s often where the clinical picture first starts to slip.
The fixes aren’t mysterious. A longer first visit can prevent confusion that compounds over months. Integrated mental health support surfaces concerns that might otherwise go unspoken.
Clear communication across the care team eliminates the mixed messages that erode confidence.
Postpartum services like pelvic floor therapy and lactation support – when easy to access and clearly explained – extend the impact of care well beyond delivery.
Workforce shortages and financial pressure make all of this harder. They also make it more urgent.
When women feel respected and informed, they raise concerns earlier, follow care plans more consistently, and seek help sooner.
That’s not a soft outcome – that’s how complications get prevented.
Simply put: adjusting how care is delivered is one of the most direct ways to improve clinical outcomes.
Entrepreneur3 weeks agoThree sessions that show exactly where women’s health is heading in 2026
Pregnancy3 weeks agoHow NIPT has evolved and what AI NIPT means in 2026
Menopause4 weeks agoWatchdog bans five ads for women’s heath claims
Entrepreneur4 weeks agoWHIS USA 2026 announces first ticket release for landmark Women’s Health Innovation Summit
Menopause4 weeks agoMenopause has no lasting impact on cognition, research finds
News3 weeks agoTwo weeks left to make your mark in women’s cardiovascular health
Opinion3 weeks agoQ1 momentum: Female founders are advancing, but the system still hasn’t caught up
News4 weeks agoEndometriosis firm wins NIH prize














